0001567619-19-009487.txt : 20190430 0001567619-19-009487.hdr.sgml : 20190430 20190430175139 ACCESSION NUMBER: 0001567619-19-009487 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190411 FILED AS OF DATE: 20190430 DATE AS OF CHANGE: 20190430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUBOW JORDAN CENTRAL INDEX KEY: 0001775155 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37977 FILM NUMBER: 19783794 MAIL ADDRESS: STREET 1: 10-1 BLANCHARDSTOWN CORPORATE PARK STREET 2: BALLYCOOLIN CITY: DUBLIN STATE: L2 ZIP: 15 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001012477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK STREET 2: BALLYCOOLIN CITY: DUBLIN STATE: L2 ZIP: 15 BUSINESS PHONE: 636-449-1830 MAIL ADDRESS: STREET 1: 16640 CHESTERFIELD GROVE ROAD STREET 2: SUITE 200 CITY: CHESTERFIELD STATE: MO ZIP: 63005 FORMER COMPANY: FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA DATE OF NAME CHANGE: 19960422 4 1 doc1.xml FORM 4 X0306 4 2019-04-11 0 0001012477 AVADEL PHARMACEUTICALS PLC AVDL 0001775155 DUBOW JORDAN BLOCK 10-1, BLANCHARDSTOWN CORPORATE PARK, BALLYCOOLIN DUBLIN L2 15 IRELAND 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 1.44 2019-04-11 4 A 0 340000 1.44 A 2029-04-11 ADSs 340000 340000 D Options become exercisable as to 85,000 ADSs on each of the first four anniversaries after the 04/11/2019 grant date. The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts. Remarks to Table I: No non-derivative securities are beneficially owned. /s/ Phillandas T. Thompson as attorney-in-fact for Jordan Dubow, M.D. 2019-04-30